Compare PROK & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PROK | ALCO |
|---|---|---|
| Founded | 2015 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 316.0M | 297.3M |
| IPO Year | 2021 | 1994 |
| Metric | PROK | ALCO |
|---|---|---|
| Price | $1.92 | $40.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $7.40 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 1.1M | 15.5K |
| Earning Date | 05-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.32 |
| Revenue | ★ $893,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $30.50 |
| Revenue Growth | ★ 1075.00 | N/A |
| 52 Week Low | $1.30 | $31.32 |
| 52 Week High | $3.48 | $45.01 |
| Indicator | PROK | ALCO |
|---|---|---|
| Relative Strength Index (RSI) | 69.27 | 52.06 |
| Support Level | $1.56 | $39.97 |
| Resistance Level | $2.22 | $42.05 |
| Average True Range (ATR) | 0.11 | 0.78 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 100.00 | 44.61 |
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
Alico Inc is a Florida-based agribusiness and land management company that mainly focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers the majority of the revenue as the firm's primary operating business unit.